Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry

被引:59
作者
Sun, Xiaorong [1 ,2 ]
Li, Xiao-Feng [1 ]
Russell, James [1 ]
Xing, Ligang [1 ,3 ]
Urano, Muneyasu [1 ]
Li, Gloria C. [1 ,3 ]
Humm, John L. [1 ]
Ling, C. Clifton [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA
[2] Shandong Canc Hosp & Inst, Dept Nucl Med, Jinan, Shandong, Peoples R China
[3] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
hypoxia; pimonidazole; EF5; mild temperature hyperthermia; blood flow;
D O I
10.1016/j.radonc.2008.05.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study the changes in hypoxia resulting from mild temperature hyperthermia (MTH) in a subcutaneous xenograft model using dual-tracer immunohistochemical techniques. Materials and methods: HT29 tumors were locally heated at 41 degrees C. Changes in tumor hypoxia were investigated by pimonidazole and EF5. Pimonidazole was given 1 h preheating, EF5 at various times during or after treatment, 1 h later the animals were sacrificed. Blood vessels were identified by CD31 staining, and perfusion by Hoechst 33342 injected 1 min pre-sacrifice. Results: The overall hypoxic fraction was significantly decreased by MTH during and immediately after heating. However, MTH induced both increases and decreases in tumor hypoxia in different parts of the tumor. Specifically, MTH decreased hypoxia in the regions with relatively well-perfused blood vessels, but increased hypoxia in regions that were poorly perfused. At 24-h post heating, newly formed hypoxic regions surrounded previously-hypoxic foci, which in turn surrounded pimonidazole-stained debris. Quantitative analysis did not evince changes in tumor oxygenation due to MTH at 24 h post-treatment. Conclusion: In this xenograft model, the effect of MTH on tumor oxygenation was variable, both spatially and kinetically. Overall tumor oxygenation was improved during and after heating, but the effect was short-lived. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 31 条
  • [1] Brizel DM, 1996, CANCER RES, V56, P941
  • [2] Brizel DM, 1996, CANCER RES, V56, P5347
  • [3] HALL EJ, 1984, CANCER RES, V44, P4708
  • [4] Harima Y, 2001, INT J HYPERTHER, V17, P97
  • [5] Hypoxia - A key regulatory factor in tumour growth
    Harris, AL
    [J]. NATURE REVIEWS CANCER, 2002, 2 (01) : 38 - 47
  • [6] Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
    Höckel, M
    Vaupel, P
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (04): : 266 - 276
  • [7] Can mild hyperthermia improve tumour oxygenation?
    Horsman, MR
    Overgaard, J
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1997, 13 (02) : 141 - 147
  • [8] A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker
    Kleiter, MM
    Thrall, DE
    Malarkey, DE
    Ji, XS
    Lee, DYW
    Chou, SC
    Raleigh, JA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02): : 592 - 602
  • [9] Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy
    Li, Xiao-Feng
    Carlin, Sean
    Urano, Muneyasu
    Russell, James
    Ling, C. Clifton
    O'Donoghue, Joseph A.
    [J]. CANCER RESEARCH, 2007, 67 (16) : 7646 - 7653
  • [10] Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers
    Ljungkvist, Anna S. E.
    Bussink, Johan
    Kaanders, Johannes H. A. M.
    van der Kogel, Albert J.
    [J]. RADIATION RESEARCH, 2007, 167 (02) : 127 - 145